Form 4: Tyra Biosciences CEO Receives Stock Grant
Insider Transaction (Form 4)
Todd Harris, President and CEO and a Director of Tyra Biosciences, Inc., received 864 shares of common stock on September 15, 2026.
Summary
- Grant/award: acquired 864 Common Stock at $9.13 ($7,887) on September 15, 2026; holds 1,438,495 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Todd Harris — Director, Officer (President and CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-15 | Grant/award | Common Stock | 864 | $9 | $7.9K | 1,438,495 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-15 | Grant/award (864 shares) |
Keywords
insider transaction, Form 4, TYRA, Tyra Biosciences, Inc., neutral, Todd Harris
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.